The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies.
作者信息
van der Veer M S, de Weers M, van Kessel B, Bakker J M, Wittebol S, Parren P W H I, Lokhorst H M, Mutis T
出版信息
Blood Cancer J. 2011 Oct;1(10):e41. doi: 10.1038/bcj.2011.42. Epub 2011 Oct 28.
Abstract
摘要
Zotero 插件